Dan Sincavage

Private equity

The value creation plan most sponsors underwrite — and the one that actually works

Why the first hundred days after close should be spent finding structural leverage, not cutting cost.

Portrait of Dan Sincavage, founder of Synagentis Group.
Dan Sincavage
Founder, Synagentis Group
·6 min read

Every deal closes with a value creation plan attached to it. Most of them look remarkably alike: tighten sales productivity, rationalize the cost base, raise prices where the data supports it, and bolt on one or two adjacent assets. None of that is wrong. It is simply the part of the plan that any competent operator would find on their own, which is another way of saying it is already in the price.

The returns that separate a good outcome from an exceptional one almost never come from executing the obvious plan faster. They come from finding the leverage that was not underwritten — capability the company already has but has never priced, packaged, or positioned. That is the work I care about, and it has to start in the first hundred days, because after that the organization has already decided what kind of company it is going to be for the rest of the hold period.

The thesis gap

There is always a gap between the thesis on paper and the operating reality in the first quarter post-close. The thesis was built from a data room, management presentations, and a market study. The reality is a sales team with habits, a product roadmap with commitments, and a customer base whose actual buying behavior rarely matches the segmentation slide.

The gap shows up in predictable places. Revenue attributed to a motion the company cannot repeat. A pipeline coverage ratio that assumes a conversion rate nobody has hit in six quarters. An expansion number that is really one large customer renewing early. None of this is deception; it is the ordinary drift between how a business explains itself and how it actually works.

The first job after close is to close that gap honestly, in writing, before anyone is asked to commit to a number. In practice that means four weeks of evidence gathering: win/loss interviews with recent buyers and recent losses, a cohort view of retention by acquisition source, a hard look at which deals the partner channel actually influenced, and direct conversations with the engineers who know which parts of the platform are load-bearing.

The most expensive mistake in the first hundred days is reorganizing before you understand what the business is actually good at.

Where the real leverage sits

Once the evidence is on the table, structural leverage tends to cluster in four places. They are not equally available in every business, but in twenty years of operating and advising I have not seen a company where at least two of them were fully harvested.

  • Positioning and category framing. Companies routinely sell a narrow product into a category that prices it as a feature. Reframing what the company is — and which budget it competes for — changes the deal size and the buyer without changing the code.
  • Ecosystem and partner-led routes to market. The cheapest incremental pipeline in most enterprise businesses comes from a partner's field organization, not a new sales hire. It requires the partnership to be built around the partner's compensation, not your roadmap.
  • Pricing and packaging architecture. Not a price increase — an architecture. What is metered, what is bundled, what sits behind an upgrade, and how a customer's success mechanically produces expansion revenue.
  • Bolt-on M&A that compounds the platform. Acquisitions that add a capability the existing distribution can immediately sell, rather than acquisitions that add revenue the platform then has to carry.

What these have in common is that they raise the value of capability that already exists. They do not require the business to become good at something new under time pressure, which is the single most reliable way to miss a plan.

Sequencing the first two quarters

Sequencing matters more than ambition. A plan with nine priorities is a plan with none, and the organization will quietly choose for you.

Weeks one through four are for evidence, not action. No reorganization, no new comp plan, no repositioning. The only deliverable is a written, shared understanding of where the business actually makes money and why customers actually buy.

Weeks five through twelve are for two bets — not five — each with a named owner, a real budget, and a weekly operating review. Two fully resourced bets beat five underfunded ones in every hold period I have been part of. The bets should come directly from the leverage list above, and each should have a falsifiable proof point attached to it.

The second quarter is for proof the board can underwrite: a pricing change live with a measurable attach rate, a partner motion with sourced pipeline you can attribute, a repositioned offering closing at a larger average deal size. The point is not the revenue in the quarter. The point is establishing that the lever moves, which is what lets the sponsor underwrite it for the remaining years of the hold.

What this buys at exit

A buyer does not pay a premium for cost discipline; they assume it. They pay a premium for a growth story they can continue — evidence that the company has identified a durable source of leverage and demonstrated it works. The plan that produces that evidence has to be built in the first hundred days, because it takes the rest of the hold period to accumulate the proof.

That is the plan worth writing. Not the one that survives the investment committee, but the one that will still be legible to a buyer three years later.

Work with me on this

If this maps to a situation you're facing, I'd welcome the conversation.

dan@synagentis.com